173 related articles for article (PubMed ID: 1372817)
1. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?
Dearnaley DP; Bayly RJ; A'Hern RP; Gadd J; Zivanovic MM; Lewington VJ
Clin Oncol (R Coll Radiol); 1992 Mar; 4(2):101-7. PubMed ID: 1372817
[TBL] [Abstract][Full Text] [Related]
2. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
3. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
4. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
Montebello JF; Hartson-Eaton M
Cancer Invest; 1989; 7(2):139-60. PubMed ID: 2477119
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.
Quilty PM; Kirk D; Bolger JJ; Dearnaley DP; Lewington VJ; Mason MD; Reed NS; Russell JM; Yardley J
Radiother Oncol; 1994 Apr; 31(1):33-40. PubMed ID: 7518932
[TBL] [Abstract][Full Text] [Related]
6. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
Sciuto R; Festa A; Rea S; Pasqualoni R; Bergomi S; Petrilli G; Maini CL
J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
[TBL] [Abstract][Full Text] [Related]
8. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
9. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
Nair N
J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
[TBL] [Abstract][Full Text] [Related]
10. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
[TBL] [Abstract][Full Text] [Related]
11. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
12. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
Breen SL; Powe JE; Porter AT
J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89.
Sciuto R; Maini CL; Tofani A; Fiumara C; Scelsa MG; Broccatelli M
Nucl Med Commun; 1996 Sep; 17(9):799-804. PubMed ID: 8895908
[TBL] [Abstract][Full Text] [Related]
14. Strontium-89 for treatment of painful bone metastasis from prostate cancer.
Altman GB; Lee CA
Oncol Nurs Forum; 1996 Apr; 23(3):523-7. PubMed ID: 8801513
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
Bauman G; Charette M; Reid R; Sathya J
Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924
[TBL] [Abstract][Full Text] [Related]
16. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL
Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
[TBL] [Abstract][Full Text] [Related]
18. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
Flamm J; Burkert S
Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
Papatheofanis FJ
J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
[TBL] [Abstract][Full Text] [Related]
20. Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience.
Bashir FA; Parry JM; Windsor PM
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):591-8. PubMed ID: 18562185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
